News

Home News

24

Mar2016

Ontario’s CED Will No Longer Routinely Evaluate CDR- or pCODR-Reviewed Drug Products

/ CDR, Ontario, pCODR, What's New
Effective April 1, 2016, all drug products reviewed by the Common Drug Review (CDR) and the pan-Canadian Oncology Drug Review ... Read More

15

Mar2016

Ontario Public Drug Programs Funds INFLECTRA™ (infliximab)

/ Ontario, What's New
The Ontario Public Drug Programs (OPDP) began funding INFLECTRA™ (infliximab) as a Limited Use (LU) benefit for eligible ODB recipients, ... Read More

15

Mar2016

CADTH Call for Patient Input for INFLECTRA™ (Subsequent Entry Biologic)

/ CADTH, CDR, What's New
The Canadian Agency for Drugs and Technologies in Health (CADTH) posted a call for patient input on  March 11, ... Read More

10

Mar2016

CADTH Call for Patient Input for Etanercept SEB

/ CADTH, CDR, What's New
The Canadian Agency for Drugs and Technologies in Health (CADTH) posted a call for patient input on March 9, ... Read More

10

Mar2016

Proposal to Amend Ontario Regulation 201/96 under the Ontario Drug Benefit Act to Update Cost-Sharing Arrangements for Non-Low Income Seniors under the Ontario Drug Benefit Program

/ Ontario, What's New
The Ontario Ministry of Health and Long-Term Care (the ‘ministry’) is proposing to update recipient cost-sharing arrangements for non-low income ... Read More

26

Feb2016

Update on Procedures for the CADTH Common Drug Review and pan-Canadian Oncology Drug Review: Mandatory Disclosure of a Submitted Drug Price

/ CADTH, Canada, CDEC, CDR, pCODR, What's New
Revised Procedures for CDR and pCODR For all drug applications filed for review through either the Common Drug Review (CDR) or ... Read More

23

Feb2016

pCPA February Update – Federal Drug Plans officially join the pCPA and the full Office team is now in place

/ Canada, News, pCPA, What's New
In a recent update released to their website, the pan-Canadian Pharmaceutical Alliance (pCPA) announced 2 significant developments: The Federal Drug ... Read More

17

Feb2016

Ontario Listing of Inflectra

/ Ontario, What's New
Ontario has released the February 2016 Summary of Changes document, which includes the addition of Hospira’s Inflectra at a price ... Read More